Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2011 (2011), Article ID 964160, 6 pages
http://dx.doi.org/10.1155/2011/964160
Clinical Study

HLA Class II Alleles Susceptibility Markers of Type 1 Diabetes Fail to Specify Phenotypes of Ketosis-Prone Diabetes in Adult Tunisian Patients

1Immunology Department, La Rabta Hospital and Al Manar University Tunis, 1007 Tunis, Tunisia
2Endocrinology Department, La Rabta Hospital and Al Manar University Tunis, 1007 Tunis, Tunisia
3Biochemistry Department, La Rabta Hospital and Al Manar University Tunis, 1007 Tunis, Tunisia

Received 8 October 2010; Revised 28 December 2010; Accepted 10 January 2011

Academic Editor: A. Veves

Copyright © 2011 Lilia Laadhar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Kahn, “Report of the expert committee on the diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 20, no. 7, pp. 1183–1197, 1997. View at Google Scholar · View at Scopus
  2. A. Balasubramanyam, R. Nalini, C. S. Hampe, and M. Maldonado, “Syndromes of ketosis-prone diabetes mellitus,” Endocrine Reviews, vol. 29, no. 3, pp. 292–302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. G. E. Umpierrez, W. Woo, W. A. Hagopian et al., “Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis,” Diabetes Care, vol. 22, no. 9, pp. 1517–1523, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Piñero-Piloña and P. Raskin, “Idiopathic type 1 diabetes,” Journal of Diabetes and Its Complications, vol. 15, no. 6, pp. 328–335, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Maldonado, C. S. Hampe, L. K. Gaur et al., “Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and β-cell functional classification, prospective analysis, and clinical outcomes,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 11, pp. 5090–5098, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Mauvais-Jarvis, E. Sobngwi, R. Porcher et al., “Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of β-cell dysfunction and insulin resistance,” Diabetes, vol. 53, no. 3, pp. 645–653, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Maldonado, S. D'Amico, M. Otiniano, A. Balasubramanyam, L. Rodriguez, and E. Cuevas, “Predictors of glycaemic control in indigent patients presenting with diabetic ketoacidosis,” Diabetes, Obesity and Metabolism, vol. 7, no. 3, pp. 282–289, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. R. Maldonado, M. E. Otiniano, F. Cheema, L. Rodriguez, and A. Balasubramanyam, “Factors associated with insulin discontinuation in subjects with ketosis-prone diabetes but preserved β-cell function,” Diabetic Medicine, vol. 22, no. 12, pp. 1744–1750, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Balasubramanyam, G. Garza, L. Rodriguez et al., “Accuracy and predictive value of classification schemes for ketosis-prone diabetes,” Diabetes Care, vol. 29, no. 12, pp. 2575–2579, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Harzallah, A. B. Brahim, L. Laadhar et al., “Ketosis-onset diabetes in Tunisian adults: immunological markers and β-cell function,” The Eastern Mediterranean Health Journal, vol. 16, no. 1, pp. 70–74, 2010. View at Google Scholar · View at Scopus
  11. S. Caillat-Zucman, I. Djilali Saiah, J. Timsit et al., “Insulin dependent diabetes mellitus (IDDM): 12th International Histocompatibility Work Shop Study,” in Histocompatibility Work Shop and Conference, P. Terasaki, Ed., pp. 389–397, Oxford University Press, 1992. View at Google Scholar
  12. J. X. She, “Susceptibility to type I diabetes: HLA-DQ and DR revisited,” Immunology Today, vol. 17, no. 7, pp. 323–329, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Abid Kamoun, S. Hmida, H. Kaabi et al., “HLA polymorphism in type 1 diabetes Tunisians,” Annales de Génétique, vol. 45, no. 1, pp. 45–50, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Stayoussef, J. Benmansour, A. Q. Al-Irhayim et al., “Autoimmune type 1 diabetes genetic susceptibility encoded by human leukocyte antigen DRB1 and DQB1 genes in Tunisia,” Clinical and Vaccine Immunology, vol. 16, no. 8, pp. 1146–1150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. W. A. Hagopian, C. B. Sanjeevi, I. Kockum et al., “Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children,” Journal of Clinical Investigation, vol. 95, no. 4, pp. 1505–1511, 1995. View at Google Scholar · View at Scopus
  16. A. G. Molbak, B. Christau, B. Marner, K. Borch-Johnsen, and J. Nerup, “Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark,” Diabetic Medicine, vol. 11, no. 7, pp. 650–655, 1994. View at Google Scholar · View at Scopus
  17. R. Bouguerra, H. Alberti, L. B. Salem et al., “The global diabetes pandemic: the Tunisian experience,” European Journal of Clinical Nutrition, vol. 61, no. 2, pp. 160–165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Tuomi, A. Carlsson, H. Li et al., “Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies,” Diabetes, vol. 48, no. 1, pp. 150–157, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Stenstrom, A. Gottsäter, E. Bakhtadze, B. Berger, and G. Sundkvist, “Latent autoimmune diabetes in adults: definition, prevalence, β-cell function, and treatment,” Diabetes, vol. 54, no. 2, pp. S68–S72, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. P. Palmer, C. S. Hampe, H. Chiu, A. Goel, and B. M. Brooks-Worrell, “Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age?” Diabetes, vol. 54, no. 2, pp. S62–S67, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Horton, I. Stratton, G. F. Bottazzo et al., “Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group,” Diabetologia, vol. 42, no. 5, pp. 608–616, 1999. View at Publisher · View at Google Scholar
  22. M. Desai, E. Zeggini, V. A. Horton et al., “The variable number of tandem repeats upstream of the insulin gene is a susceptibility locus for latent autoimmune diabetes in adults,” Diabetes, vol. 55, no. 6, pp. 1890–1894, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Desai, E. Zeggini, V. A. Horton et al., “An association analysis of the HLA gene region in latent autoimmune diabetes in adults,” Diabetologia, vol. 50, no. 1, pp. 68–73, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Jenhani, R. Bardi, S. Chammakhi, M. Jeddi, and K. Ayed, “Immunogenetic heterogeneity in type I (insulin-dependent) diabetes among the Tunisian population. HLA-DR antigens and organ-specific autoantibodies (family study),” Journal of Autoimmunity, vol. 4, no. 3, pp. 553–561, 1991. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Laadhar, A. Gassara, N. Mahfoudh et al., “Susceptibility markers in Tunisian first-degree relatives of patients with type 1 diabetes,” Annales d'Endocrinologie, vol. 68, no. 2-3, pp. 181–185, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Nalini, L. K. Gaur, M. Maldonado et al., “HLA class II alleles specify phenotypes of ketosis-prone diabetes,” Diabetes Care, vol. 31, no. 6, pp. 1195–1200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Linfoot, C. Bergstrom, and E. Ipp, “Pathophysiology of ketoacidosis in type 2 diabetes mellitus,” Diabetic Medicine, vol. 22, no. 10, pp. 1414–1419, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. E. W. Kraegen, G. J. Cooney, J. M. Ye, A. L. Thompson, and S. M. Furler, “The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity,” Experimental and Clinical Endocrinology and Diabetes, vol. 109, no. 2, pp. S189–S201, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. W. E. Winter, N. K. Maclaren, W. J. Riley, D. W. Clarke, M. S. Kappy, and R. Spillar, “Maturity-onset diabetes of youth in black Americans,” The New England Journal of Medicine, vol. 316, no. 6, pp. 285–291, 1987. View at Google Scholar
  30. E. Sobngwi, F. Mauvais-Jarvis, P. Vexiau, J. C. Mbanya, and J. F. Gautier, “Diabetes in Africans: part 2: ketosis-prone atypical diabetes mellitus,” Diabetes and Metabolism, vol. 28, no. 1, pp. 5–12, 2002. View at Google Scholar · View at Scopus
  31. R. Nalini, K. Ozer, M. Maldonado et al., “Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of "a-β+" ketosis-prone diabetes based on long-term β-cell function, human leukocyte antigen class II alleles, and sex predilection,” Metabolism: Clinical and Experimental, vol. 59, no. 10, pp. 1448–1455, 2010. View at Publisher · View at Google Scholar
  32. F. Mauvais-Jarvis, S. B. Smith, C. Le May et al., “PAX4 gene variations predispose to ketosis-prone diabetes,” Human Molecular Genetics, vol. 13, no. 24, pp. 3151–3159, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Pihoker, L. K. Gilliam, C. S. Hampe, and A. Lernmark, “Autoantibodies in diabetes,” Diabetes, vol. 54, no. 2, pp. S52–S61, 2005. View at Publisher · View at Google Scholar · View at Scopus